164 related articles for article (PubMed ID: 33890248)
21. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
[TBL] [Abstract][Full Text] [Related]
22. S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE).
Jin Q; Chen H; Luo A; Ding F; Liu Z
PLoS One; 2011 Apr; 6(4):e19375. PubMed ID: 21559403
[TBL] [Abstract][Full Text] [Related]
23. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
Al-Azayzih A; Gao F; Somanath PR
Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
[TBL] [Abstract][Full Text] [Related]
24. IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway.
Lu J; Yang Y; Guo G; Liu Y; Zhang Z; Dong S; Nan Y; Zhao Z; Zhong Y; Huang Q
Oncotarget; 2017 Jul; 8(30):49502-49514. PubMed ID: 28548934
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of didscoidin domain receptor 1 reduces epithelial-mesenchymal transition and induce cell-cycle arrest and apoptosis in prostate cancer cell lines.
Azizi R; Salemi Z; Fallahian F; Aghaei M
J Cell Physiol; 2019 Nov; 234(11):19539-19552. PubMed ID: 30963567
[TBL] [Abstract][Full Text] [Related]
26. A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis.
Li X; Wang M; Gong T; Lei X; Hu T; Tian M; Ding F; Ma F; Chen H; Liu Z
Theranostics; 2020; 10(13):5687-5703. PubMed ID: 32483412
[No Abstract] [Full Text] [Related]
27. S100A14: novel modulator of terminal differentiation in esophageal cancer.
Chen H; Ma J; Sunkel B; Luo A; Ding F; Li Y; He H; Zhang S; Xu C; Jin Q; Wang Q; Liu Z
Mol Cancer Res; 2013 Dec; 11(12):1542-53. PubMed ID: 24107296
[TBL] [Abstract][Full Text] [Related]
28. Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway.
Li Z; Razavi P; Li Q; Toy W; Liu B; Ping C; Hsieh W; Sanchez-Vega F; Brown DN; Da Cruz Paula AF; Morris L; Selenica P; Eichenberger E; Shen R; Schultz N; Rosen N; Scaltriti M; Brogi E; Baselga J; Reis-Filho JS; Chandarlapaty S
Cancer Cell; 2018 Dec; 34(6):893-905.e8. PubMed ID: 30537512
[TBL] [Abstract][Full Text] [Related]
29. Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer.
Hance MW; Dole K; Gopal U; Bohonowych JE; Jezierska-Drutel A; Neumann CA; Liu H; Garraway IP; Isaacs JS
J Biol Chem; 2012 Nov; 287(45):37732-44. PubMed ID: 22989880
[TBL] [Abstract][Full Text] [Related]
30. S100A14, a mediator of epithelial-mesenchymal transition, regulates proliferation, migration and invasion of human cervical cancer cells.
Wang X; Yang J; Qian J; Liu Z; Chen H; Cui Z
Am J Cancer Res; 2015; 5(4):1484-95. PubMed ID: 26101712
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma.
Ding F; Wang D; Li XK; Yang L; Liu HY; Cui W; Liu ZH; Che YQ
Thorac Cancer; 2018 Jul; 9(7):827-835. PubMed ID: 29733545
[TBL] [Abstract][Full Text] [Related]
32. mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer.
Chen X; Cheng H; Pan T; Liu Y; Su Y; Ren C; Huang D; Zha X; Liang C
Mol Carcinog; 2015 Oct; 54(10):1086-95. PubMed ID: 25043657
[TBL] [Abstract][Full Text] [Related]
33. The other face of miR-17-92a cluster, exhibiting tumor suppressor effects in prostate cancer.
Ottman R; Levy J; Grizzle WE; Chakrabarti R
Oncotarget; 2016 Nov; 7(45):73739-73753. PubMed ID: 27650539
[TBL] [Abstract][Full Text] [Related]
34. Activation of Notch pathway is linked with epithelial-mesenchymal transition in prostate cancer cells.
Zhang L; Sha J; Yang G; Huang X; Bo J; Huang Y
Cell Cycle; 2017 May; 16(10):999-1007. PubMed ID: 28388267
[TBL] [Abstract][Full Text] [Related]
35. Notch-4 silencing inhibits prostate cancer growth and EMT via the NF-κB pathway.
Zhang J; Kuang Y; Wang Y; Xu Q; Ren Q
Apoptosis; 2017 Jun; 22(6):877-884. PubMed ID: 28374086
[TBL] [Abstract][Full Text] [Related]
36. The diverse functions of FAT1 in cancer progression: good, bad, or ugly?
Chen ZG; Saba NF; Teng Y
J Exp Clin Cancer Res; 2022 Aug; 41(1):248. PubMed ID: 35965328
[TBL] [Abstract][Full Text] [Related]
37. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
[TBL] [Abstract][Full Text] [Related]
38. Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer.
Elshafae SM; Hassan BB; Supsavhad W; Dirksen WP; Camiener RY; Ding H; Tweedle MF; Rosol TJ
Prostate; 2016 Jun; 76(9):796-809. PubMed ID: 26939805
[TBL] [Abstract][Full Text] [Related]
39. [Citron Rho-interacting serine/threonine kinase knockdown suppresses prostate cancer cell proliferation and metastasis by blocking Hippo-YAP pathway].
Haiping C; Qi X; Dawei L; Qiang W
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Mar; 39(3):257-263. PubMed ID: 31068310
[TBL] [Abstract][Full Text] [Related]
40. AKT/GSK-3β regulates stability and transcription of snail which is crucial for bFGF-induced epithelial-mesenchymal transition of prostate cancer cells.
Liu ZC; Wang HS; Zhang G; Liu H; Chen XH; Zhang F; Chen DY; Cai SH; Du J
Biochim Biophys Acta; 2014 Oct; 1840(10):3096-105. PubMed ID: 25088797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
